Charles Ryhee
Stock Analyst at TD Cowen
(2.47)
# 2,149
Out of 4,829 analysts
25
Total ratings
52.38%
Success rate
0.31%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $64.81 | +23.44% | 5 | Nov 25, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Buy | $16 → $14 | $11.40 | +22.81% | 6 | Oct 22, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $687.52 | -5.17% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $141.62 | +20.04% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $9.25 | +538.18% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $148.58 | -51.54% | 1 | Aug 16, 2022 | |
| OTRK Ontrak | Downgrades: Underperform | $3,150 → $810 | $1.70 | +47,547.06% | 2 | Aug 20, 2021 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $7.36 | +2,454.35% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $16.82 | +72.41% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $64.81
Upside: +23.44%
Walgreens Boots Alliance
Oct 22, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $11.40
Upside: +22.81%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $687.52
Upside: -5.17%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $141.62
Upside: +20.04%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $9.25
Upside: +538.18%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $148.58
Upside: -51.54%
Ontrak
Aug 20, 2021
Downgrades: Underperform
Price Target: $3,150 → $810
Current: $1.70
Upside: +47,547.06%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $7.36
Upside: +2,454.35%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $16.82
Upside: +72.41%